Search results

4 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
New gene therapy proves promising as hemophilia treatment
Researchers package specialized blood platelets with genes that express clotting factor, leading to fewer bleeding events.
Located in News / 2013 / December
New gene therapy for hemophilia shows potential as safe treatment
Research showed that bleeding events were drastically decreased in animals with hemophilia B. Using a viral vector to swap out faulty genes proved safe and could be used for the more common hemophilia A.
Located in News / 2015 / March
Remembering renowned blood researcher Harold Roberts
This past weekend, long-time UNC School of Medicine professor Harold Roberts, MD, passed away. He and Kenneth Brinkhous developed the first highly purified factor VIII, which remains the primary therapy for people with hemophilia.
Located in News / 2017 / September
Key elected International Society on Thrombosis and Haemostasis Council Chair
Nigel S. Key, MD, MB, ChB, FRCP, Harold R. Roberts Professor, is the director of the UNC Hemophilia and Thrombosis Center.
Located in Vital Signs / 2014 / Aug. 14